<br /> SCHWAZZE ANNOUNCES EARNINGS CALL & PARTICIPATION IN UPCOMING CONFERENCES & EVENTS<br />

SCHWAZZE ANNOUNCES EARNINGS CALL & PARTICIPATION IN UPCOMING CONFERENCES & EVENTS

Canada NewsWire

DENVER

,

Nov. 1, 2022

/CNW/ – Medicine Man Technologies operating as

Schwazze

, (OTCQX: SHWZ) (NEO: SHWZ)

(“Schwazze”

or the

“Company”),

is pleased to announce that

Justin Dye

, Chairman & CEO;

Nirup Krishnamurthy

, President; and

Nancy Huber

, CFO will host the Schwazze Third Quarter conference call on

November 9, 2022

,

at

5:00 pm ET

.

Investors and stakeholders may participate in the conference call by dialing 416-764-8650 or by dialing North American toll free 1-888-664-6383 or listen to the webcast from the Company’s website at

https://ir.schwazze.com

The webcast will be available on the Company’s website and on replay until

November 16, 2022

, and may be accessed by dialing 1-888-390-0541 / 997573 #.

Following their prepared remarks, Chief Executive Officer,

Justin Dye

; President,

Nirup Krishnamurthy

; and Chief Financial Officer,

Nancy Huber

will answer investor questions. Investors may submit questions in advance or during the conference call itself through the weblink:

https://app.webinar.net/x0q6rpnP84n

This weblink has been posted to the Company’s website and will be archived on the website. All Company SEC filings can also be accessed on the Company website at

https://ir.schwazze.com/sec-filings

Upcoming Events:

MJ BizCon –

Las Vegas

,

November 16-18, 2022

Justin Dye

, Chairman & CEO and

Nancy Huber

, CFO will be attending MJ BizCon Las Vegas

November 16-18

at the Las Vegas Convention Centre. Management will also be participating in one-on-one investor meetings at the event

(Booth #

3007

)

. For more information or to schedule a meeting please contact

Joanne Jobin

, IRO at

[email protected]

.

Benchmark 11
^th
Annual Discovery Conference –

New York City

–

December 1, 2022

Justin Dye

, Chairman & CEO and

Nancy Huber

, CFO will participate in the afternoon session of the Benchmark 11
^th
Annual Discovery Conference at the New York Athletic Club, 180 Central Park South in Manhattan. Management will be participating in one-on-one investor meetings throughout the conference. For more information, please contact your Benchmark representative.

About Schwazze

Schwazze (OTCQX:SHWZ, NEO:SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and

New Mexico

and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,”, “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in

Colorado

and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws, and * out ability to satisfy the closing conditions for the private finding described in this press release. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at

http://www.sec.gov

. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

View original content to download multimedia:

https://www.prnewswire.com/news-releases/schwazze-announces-earnings-call–participation-in-upcoming-conferences–events-301664013.html